Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine

Skeletal muscle catabolism, low plasma glutamine, and high venous glutamate levels are common among patients with cancer or human immunodeficiency virus infection. In addition, a high glycolytic activity is commonly found in muscle tissue of cachectic cancer patients, suggesting insufficient mitocho...

Full description

Saved in:
Bibliographic Details
Main Authors: Kinscherf, Ralf (Author) , Hack, Volker (Author) , Fischbach, Thomas (Author) , Friedmann-Bette, Birgit (Author) , Weiß, Christel (Author) , Edler, Lutz (Author) , Bärtsch, Peter (Author) , Dröge, Wulf (Author)
Format: Article (Journal)
Language:English
Published: July 1996
In: Journal of molecular medicine
Year: 1996, Volume: 74, Issue: 7, Pages: 393-400
ISSN:1432-1440
DOI:10.1007/BF00210633
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/BF00210633
Get full text
Author Notes:R. Kinscherf, V. Hack, T. Fischbach, B. Friedmann, C. Weiss, L. Edler, P. Bärtsch, W. Dröge

MARC

LEADER 00000caa a2200000 c 4500
001 1878312367
003 DE-627
005 20240311151617.0
007 cr uuu---uuuuu
008 240117s1996 xx |||||o 00| ||eng c
024 7 |a 10.1007/BF00210633  |2 doi 
035 |a (DE-627)1878312367 
035 |a (DE-599)KXP1878312367 
035 |a (OCoLC)1425891570 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kinscherf, Ralf  |e VerfasserIn  |0 (DE-588)1084823748  |0 (DE-627)848747925  |0 (DE-576)169729516  |4 aut 
245 1 0 |a Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals  |b the effect of N-acetyl-cysteine  |c R. Kinscherf, V. Hack, T. Fischbach, B. Friedmann, C. Weiss, L. Edler, P. Bärtsch, W. Dröge 
264 1 |c July 1996 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.01.2024 
520 |a Skeletal muscle catabolism, low plasma glutamine, and high venous glutamate levels are common among patients with cancer or human immunodeficiency virus infection. In addition, a high glycolytic activity is commonly found in muscle tissue of cachectic cancer patients, suggesting insufficient mitochondrial energy metabolism. We therefore investigated (a) whether an “anaerobic physical exercise” program causes similar changes in plasma amino acid levels, and (b) whether low plasma glutamine or high glutamate levels are risk factors for loss of body cell mass (BCM) in healthy human subjects, i.e., in the absence of a tumor or virus infection. Longitudinal measurements from healthy subjects over longer periods suggest that the age-related loss of BCM occur mainly during episodes with high venous glutamate levels, indicative of decreased muscular transport activity for glutamate. A significant increase in venous glutamate levels from 25 to about 40 μM was seen after a program of “anaerobic physical exercise.” This was associated with changes in T lymphocyte numbers. Under these conditions persons with low baseline levels of plasma glutamine, arginine, and cystine levels also showed a loss of BCM. This loss of BCM was correlated not only with the amino acid levels at baseline examination, but also with an increase in plasma glutamine, arginine, and cystine levels during the observation period, suggesting that a loss of BCM in healthy individuals terminates itself by adjusting these amino acids to higher levels that stabilize BCM. To test a possible regulatory role of cysteine in this context we determined the effect of N-acetyl-cysteine on BCM in a group of subjects with relatively low glutamine levels. The placebo group of this study showed a loss of BCM and an increase in body fat, suggesting that body protein had been converted into other forms of chemical energy. The decrease in mean BCM/body fat ratios was prevented by N-acetyl-cysteine, indicating that cysteine indeed plays a regulatory role in the physiological control of BCM. 
650 4 |a Anaerobic exercise 
650 4 |a Body cell mass 
650 4 |a Cachexia 
650 4 |a Cysteine effect on BCM 
650 4 |a N-Acetyl-cysteine effect on body cell mass 
700 1 |a Hack, Volker  |d 1961-  |e VerfasserIn  |0 (DE-588)172728053  |0 (DE-627)697660060  |0 (DE-576)133585484  |4 aut 
700 1 |a Fischbach, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Friedmann-Bette, Birgit  |d 1960-  |e VerfasserIn  |0 (DE-588)112694195  |0 (DE-627)519225937  |0 (DE-576)289739683  |4 aut 
700 1 |a Weiß, Christel  |d 1958-  |e VerfasserIn  |0 (DE-588)123287707  |0 (DE-627)082463417  |0 (DE-576)168356104  |4 aut 
700 1 |a Edler, Lutz  |d 1945-  |e VerfasserIn  |0 (DE-588)143483293  |0 (DE-627)646571796  |0 (DE-576)167028103  |4 aut 
700 1 |a Bärtsch, Peter  |e VerfasserIn  |0 (DE-588)1068984023  |0 (DE-627)821117483  |0 (DE-576)428341179  |4 aut 
700 1 |a Dröge, Wulf  |d -2011  |e VerfasserIn  |0 (DE-588)1178587789  |0 (DE-627)1049465539  |0 (DE-576)517837528  |4 aut 
773 0 8 |i Enthalten in  |t Journal of molecular medicine  |d Berlin : Springer, 1995  |g 74(1996), 7, Seite 393-400  |h Online-Ressource  |w (DE-627)254630804  |w (DE-600)1462132-0  |w (DE-576)079420028  |x 1432-1440  |7 nnas  |a Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals the effect of N-acetyl-cysteine 
773 1 8 |g volume:74  |g year:1996  |g number:7  |g pages:393-400  |g extent:8  |a Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals the effect of N-acetyl-cysteine 
856 4 0 |u https://doi.org/10.1007/BF00210633  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240117 
993 |a Article 
994 |a 1996 
998 |g 1178587789  |a Dröge, Wulf  |m 1178587789:Dröge, Wulf  |d 50000  |e 50000PD1178587789  |k 0/50000/  |p 8  |y j 
998 |g 1068984023  |a Bärtsch, Peter  |m 1068984023:Bärtsch, Peter  |d 910000  |d 910100  |e 910000PB1068984023  |e 910100PB1068984023  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 143483293  |a Edler, Lutz  |m 143483293:Edler, Lutz  |d 50000  |e 50000PE143483293  |k 0/50000/  |p 6 
998 |g 123287707  |a Weiß, Christel  |m 123287707:Weiß, Christel  |d 60000  |d 60200  |d 60250  |e 60000PW123287707  |e 60200PW123287707  |e 60250PW123287707  |k 0/60000/  |k 1/60000/60200/  |k 2/60000/60200/60250/  |p 5 
998 |g 112694195  |a Friedmann-Bette, Birgit  |m 112694195:Friedmann-Bette, Birgit  |d 910000  |d 910100  |e 910000PF112694195  |e 910100PF112694195  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 172728053  |a Hack, Volker  |m 172728053:Hack, Volker  |p 2 
998 |g 1084823748  |a Kinscherf, Ralf  |m 1084823748:Kinscherf, Ralf  |d 50000  |e 50000PK1084823748  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1878312367  |e 4459974789 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Kinscherf, Ralf","role":"aut","given":"Ralf","family":"Kinscherf"},{"display":"Hack, Volker","role":"aut","family":"Hack","given":"Volker"},{"display":"Fischbach, Thomas","role":"aut","family":"Fischbach","given":"Thomas"},{"role":"aut","display":"Friedmann-Bette, Birgit","given":"Birgit","family":"Friedmann-Bette"},{"family":"Weiß","given":"Christel","display":"Weiß, Christel","role":"aut"},{"role":"aut","display":"Edler, Lutz","family":"Edler","given":"Lutz"},{"family":"Bärtsch","given":"Peter","role":"aut","display":"Bärtsch, Peter"},{"family":"Dröge","given":"Wulf","role":"aut","display":"Dröge, Wulf"}],"title":[{"title_sort":"Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals","title":"Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals","subtitle":"the effect of N-acetyl-cysteine"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals the effect of N-acetyl-cysteineJournal of molecular medicine","language":["eng"],"part":{"year":"1996","volume":"74","extent":"8","pages":"393-400","text":"74(1996), 7, Seite 393-400","issue":"7"},"title":[{"title_sort":"Journal of molecular medicine","title":"Journal of molecular medicine"}],"id":{"zdb":["1462132-0"],"eki":["254630804"],"issn":["1432-1440"]},"pubHistory":["Volume 73, issue 1 (January 1995)-"],"recId":"254630804","physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Springer","dateIssuedDisp":"1995-","publisherPlace":"Berlin ; Heidelberg ; New York, NY","dateIssuedKey":"1995"}],"note":["Gesehen am 14.03.25"]}],"physDesc":[{"extent":"8 S."}],"note":["Gesehen am 17.01.2024"],"origin":[{"dateIssuedKey":"1996","dateIssuedDisp":"July 1996"}],"id":{"doi":["10.1007/BF00210633"],"eki":["1878312367"]},"name":{"displayForm":["R. Kinscherf, V. Hack, T. Fischbach, B. Friedmann, C. Weiss, L. Edler, P. Bärtsch, W. Dröge"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1878312367"} 
SRT |a KINSCHERFRLOWPLASMAG1996